These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23721579)

  • 21. Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitol Res; 2011 Oct; 109(4):981-95. PubMed ID: 21442257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs.
    Alvarez L; Moreno G; Moreno L; Ceballos L; Shaw L; Fairweather I; Lanusse C
    Vet Parasitol; 2009 Oct; 164(2-4):211-6. PubMed ID: 19560276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Exp Parasitol; 2013 Nov; 135(3):642-53. PubMed ID: 24090567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A major locus confers triclabendazole resistance in Fasciola hepatica and shows dominant inheritance.
    Beesley NJ; Cwiklinski K; Allen K; Hoyle RC; Spithill TW; La Course EJ; Williams DJL; Paterson S; Hodgkinson JE
    PLoS Pathog; 2023 Jan; 19(1):e1011081. PubMed ID: 36701396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of nitroxynil against Fasciola hepatica resistant to triclabendazole in a naturally infected sheep flock.
    Martínez-Valladares M; del Rosario Famularo M; Fernández-Pato N; Castañón-Ordóñez L; Cordero-Pérez C; Rojo-Vázquez FA
    Parasitol Res; 2010 Oct; 107(5):1205-11. PubMed ID: 20680341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase of carboxylesterase activity in Fasciola hepatica recovered from triclabendazole treated sheep.
    Scarcella S; Miranda-Miranda E; Cossío-Bayúgar R; Ceballos L; Fernandez V; Solana H
    Mol Biochem Parasitol; 2012 Oct; 185(2):151-3. PubMed ID: 22814337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening anthelmintic resistance to triclabendazole in Fasciola hepatica isolated from sheep by means of an egg hatch assay.
    Robles-Pérez D; Martínez-Pérez JM; Rojo-Vázquez FA; Martínez-Valladares M
    BMC Vet Res; 2015 Aug; 11():226. PubMed ID: 26314580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative proteomic analysis of triclabendazole response in the liver fluke Fasciola hepatica.
    Chemale G; Perally S; LaCourse EJ; Prescott MC; Jones LM; Ward D; Meaney M; Hoey E; Brennan GP; Fairweather I; Trudgett A; Brophy PM
    J Proteome Res; 2010 Oct; 9(10):4940-51. PubMed ID: 20726552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triclabendazole progress report, 2005-2009: an advancement of learning?
    Fairweather I
    J Helminthol; 2009 Jun; 83(2):139-50. PubMed ID: 19366485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil.
    Meaney M; Savage J; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Parasitology; 2013 Sep; 140(10):1287-303. PubMed ID: 23756576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes.
    Ceballos L; Moreno L; Alvarez L; Shaw L; Fairweather I; Lanusse C
    BMC Vet Res; 2010 Feb; 6():8. PubMed ID: 20128898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding triclabendazole resistance.
    Brennan GP; Fairweather I; Trudgett A; Hoey E; McCoy ; McConville M; Meaney M; Robinson M; McFerran N; Ryan L; Lanusse C; Mottier L; Alvarez L; Solana H; Virkel G; Brophy PM
    Exp Mol Pathol; 2007 Apr; 82(2):104-9. PubMed ID: 17398281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of two assays, a faecal egg count reduction test (FECRT) and a coproantigen reduction test (CRT), for the diagnosis of resistance to triclabendazole in Fasciola hepatica in sheep.
    Flanagan A; Edgar HW; Gordon A; Hanna RE; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Mar; 176(2-3):170-6. PubMed ID: 21112153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect.
    Mottier L; Alvarez L; Fairweather I; Lanusse C
    J Parasitol; 2006 Dec; 92(6):1355-60. PubMed ID: 17304820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis of triclabendazole resistance in Fasciola hepatica.
    Sargison N
    Vet Rec; 2012 Aug; 171(6):151-2. PubMed ID: 22890399
    [No Abstract]   [Full Text] [Related]  

  • 36. Composite faecal egg count reduction test to detect resistance to triclabendazole in Fasciola hepatica.
    Daniel R; van Dijk J; Jenkins T; Akca A; Mearns R; Williams DJ
    Vet Rec; 2012 Aug; 171(6):153, 1-5. PubMed ID: 22791519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance of Fasciola hepatica against triclabendazole in cattle in Patagonia (Argentina).
    Olaechea F; Lovera V; Larroza M; Raffo F; Cabrera R
    Vet Parasitol; 2011 Jun; 178(3-4):364-6. PubMed ID: 21277090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraspecific mitochondrial DNA variation of Fasciola hepatica eggs from sheep with different level of anthelmintic resistance.
    Martínez-Valladares M; Rojo-Vázquez FA
    Parasitol Res; 2014 Jul; 113(7):2733-41. PubMed ID: 24832814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain.
    Alvarez-Sánchez MA; Mainar-Jaime RC; Pérez-García J; Rojo-Vázquez FA
    Vet Rec; 2006 Sep; 159(13):424-5. PubMed ID: 16998003
    [No Abstract]   [Full Text] [Related]  

  • 40. Pilot Evaluation of Two
    Collett CF; Morphew RM; Timson D; Phillips HC; Brophy PM
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32751696
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.